Open AccessDiagnostic and treatment options for patients with COPD as part of real clinical practice. Approaches to the treatment of patients with various phenotypes according to GOLD (2019): materials of the Council of Experts of the Siberian Federal District, Chita and Buryatia, dated 03.15.19
Author(s) -
И. В. Демко,
L. M. Kudelya,
Е. А. Собко,
И. А. Соловьева,
И. Н. Трофименко,
А. В. Тетенева,
A. A. Grebenyuk,
N. G. Ganyukova,
Н С Гыргешкинова,
Sergey Lukyanov,
Ch. Ch. Mandarzhap,
O. A. Meshcheryakova
Publication year - 2020
Publication title -
pulʹmonologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 6
eISSN - 2541-9617
pISSN - 0869-0189
DOI - 10.18093/0869-0189-2020-30-2-245-251
Subject(s) - copd , medicine , intensive care medicine , pulmonary disease , obstructive lung disease , disease , clinical practice , precision medicine , physical therapy , pathology
Chronic obstructive pulmonary disease (COPD) is a global problem in modern medicine. In recent years, the medical community’s understanding of COPD has changed significantly, which is primarily due to the emergence of a new classification and the identification of various phenotypes of the disease. These changes could not affect the tactics of COPD treatment. The article discusses not only the debatable issues of treating COPD; it provides an overview of changes in international (Global Initiative for Chronic Obstructive Lung Disease, 2018) and national (2019) recommendations, but also the significance and benefits of triple therapy in terms of evidence-based medicine as well as the benefits of extra-fine drugs in the treatment of bronchial obstructive syndrome.